Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection

Inclusion Criteria

• •18≤Age≤65;
• •ECOG performance status of 0 or 1;
• •Pathological diagnosis with Stage IIIA-N2 NSCLC which is clinically resectable and the N2 is diagnosed by either mediastinoscopy,EBUS,PET/CT;
• •WBC≥4.0×109/l, ANC≥1.5×109/l, PLT≥100.0×109/l, Hb≥90g/l;hepatorenal function is normal;
• •Without a history of other malignancies before enrollment, except for non-melanoma skin cancer, in situ cervical cancer;
• •The patient can understand the research and sign the informed consent.